Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MSN

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 31
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

CHANGZHOU PHARM

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 28
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 26
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text

AZURITY

  • FDA Approval
  • Oct. 28, 2025, 15:49 UTC
  • 20
  • 0 comments

FDA approve CABOZANTINIB

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 19
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 21
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text

AJENAT PHARMS

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 20
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

ALKEM LABORATORIES LIMITED

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 18
  • 0 comments

FDA approve BEMPEDOIC ACID, EZETIMIBE

Comment Full text

DR REDDYS

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 18
  • 0 comments

FDA approve DOCOSANOL

Comment Full text

AMPHASTAR PHARMS INC

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 18
  • 0 comments

FDA approve NEOSTIGMINE METHYLSULFATE

Comment Full text
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Search

News categories

  • Technical Exchange News(10560)
  • Event(1910)
  • SEC News(183278)
  • FDA Approval(9799)
  • Company Report(721)
  • Business News(121533)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin